HDAC9 and cancer: Human cancer cells treated with HDAC inhibitors, arsenic trioxide, TNF-α, IFN- γ, rapamycin, and antiestrogen hormonal therapy activate autophagy as a pro-survival strategy, suggesting that inhibiting autophagy might make cancer cells more sensitive to these treatments (289–294).